Literature DB >> 10630329

Fluconazole use in burns patients.

S Rayatt1, M Wienbren, J Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10630329     DOI： 10.1016/s0305-4179(99)00101-1

Source DB:  PubMed          Journal:  Burns        ISSN： 0305-4179            Impact factor:   2.744


× No keyword cloud information.
  5 in total

1.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

2.  Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection.

Authors:  Seunghoon Han; Jimyon Kim; Haejun Yim; Jun Hur; Wonkeun Song; Jongtae Lee; Sangil Jeon; Taegon Hong; Heungjeong Woo; Dong-Seok Yim
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

3.  Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients.

Authors:  Silvia Regina Cavani Jorge Santos; Edvaldo Vieira Campos; Cristina Sanches; David Souza Gomez; Marcus Castro Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

4.  Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.

Authors:  A García-de-Lorenzo; S Luque; S Grau; A Agrifoglio; L Cachafeiro; E Herrero; M J Asensio; S M Sánchez; J A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 5.  Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.

Authors:  Benoit Blanchet; Vincent Jullien; Christophe Vinsonneau; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.